Australia's most trusted
source of pharma news
Thursday, 27 November 2025
Posted 27 November 2025 AM
Eli Lilly has become the first trillion-dollar pharma. The drugmaker hit a US$1 trillion valuation on the US stockmarket on Friday, having added more than US$400 billion to its market cap since early August.
In 2017, when Dave Ricks took over as CEO, the company was worth US$81 billion.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.